PubRank
Search
About
Diane K Reyes
Author PubWeight™ 13.38
‹?›
Top papers
Rank
Title
Journal
Year
PubWeight™
‹?›
1
Phase II trial of sorafenib combined with concurrent transarterial chemoembolization with drug-eluting beads for hepatocellular carcinoma.
J Clin Oncol
2011
3.03
2
Unresectable hepatocellular carcinoma: serial early vascular and cellular changes after transarterial chemoembolization as detected with MR imaging.
Radiology
2009
2.48
3
The role of functional MR imaging in the assessment of tumor response after chemoembolization in patients with hepatocellular carcinoma.
J Vasc Interv Radiol
2006
1.47
4
Quantitative and volumetric European Association for the Study of the Liver and Response Evaluation Criteria in Solid Tumors measurements: feasibility of a semiautomated software method to assess tumor response after transcatheter arterial chemoembolization.
J Vasc Interv Radiol
2012
1.26
5
Functional MR imaging assessment of tumor response after 90Y microsphere treatment in patients with unresectable hepatocellular carcinoma.
J Vasc Interv Radiol
2007
1.20
6
Salvage therapy for liver-dominant colorectal metastatic adenocarcinoma: comparison between transcatheter arterial chemoembolization versus yttrium-90 radioembolization.
J Vasc Interv Radiol
2009
0.91
7
Phase II study of chemoembolization with drug-eluting beads in patients with hepatic neuroendocrine metastases: high incidence of biliary injury.
Cardiovasc Intervent Radiol
2012
0.86
8
Phase 2 trial of concurrent bevacizumab and transhepatic arterial chemoembolization in patients with unresectable hepatocellular carcinoma.
Cancer
2012
0.84
9
Experimental evaluation of a new transcatheter vascular embolization device in the swine model.
J Vasc Interv Radiol
2002
0.81
10
Response stratification and survival analysis of hepatocellular carcinoma patients treated with intra-arterial therapy using MR imaging-based arterial enhancement fraction.
J Magn Reson Imaging
2013
0.76
11
Complications of loco-regional therapy in the liver-spectrum of imaging findings by CT and MRI.
Emerg Radiol
2011
0.75